A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples